Interestingly their also appears to be some interaction in liver fibrosis between MeCP2 and the methyltransferase ASH1, where the increased expression of MeCP2 either through regulation of miRs or another mechanism appears to elevate ASH1 levels and increases ECM through direct binding of the genes in their promoters. The gene discussed is MECP2; the disease is Hepatic fibrosis.